Shanghai-based healthcare PE fund C-Bridge Capital has led a $20 million Series B funding round into Nuance Biotech while YuanMing Capital has invested $50 million into Series B into Adlai Nortye.
C Bridge Capital leads $20m round in Nuance Biotech
Shanghai-based healthcare PE fund C-Bridge Capital has led a $20 million Series B funding round into Nuance Biotech, a China-based specialty pharma company.
